Evidence map›Paper›PMID 42871849›Full record

ArticleOpen forum infectious diseases2026

Estimating the Range and Duration of Post-influenza Symptoms, Conditions, and Diseases.

Aaron C Miller, D Erik Boonstra, Joseph E Cavanaugh, Roger D Struble, Constantina Boikos, Tianyan Hu, Timothy L Wiemken, Verna L Welch, Philip M Polgreen

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aaron C MillerDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.ORCID https://orcid.org/0000-0002-6828-8966
D Erik BoonstraDepartment of Biostatistics, University of Iowa, Iowa City, Iowa, USA.ORCID https://orcid.org/0009-0005-1599-1809
Joseph E CavanaughDepartment of Biostatistics, University of Iowa, Iowa City, Iowa, USA.
Roger D StrubleDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.ORCID https://orcid.org/0000-0002-6814-9720
Constantina BoikosDepartment of Medical Affairs, Pfizer Inc., Kirkland, QC, Canada.
Tianyan HuPfizer Inc., New York, New York, USA.ORCID https://orcid.org/0009-0004-2660-8871
Timothy L WiemkenDepartment of Medical Affairs, Pfizer Inc., New York, New York, USA.
Verna L WelchDepartment of Medical Affairs, Pfizer Inc., New York, New York, USA.ORCID https://orcid.org/0000-0002-1316-5395
Philip M PolgreenDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.ORCID https://orcid.org/0000-0002-0630-5898

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute symptoms of influenza are understood; however, less is known about potential postacute sequelae. We conducted a retrospective matched cohort study to identify conditions with elevated risk following influenza. Methods: We analyzed data from the Merative MarketScan Research Databases (2001-2019), including 3.3 million patients with a diagnosis of influenza. Cases were matched 1:1 to patients based on similar age, sex, care setting, and enrollment period with no influenza diagnosis. We examined the frequency of diagnosis codes in the year before and after the index influenza event, applying K-means clustering to identify diagnoses with post-influenza visit patterns similar to cough, a known sequela of influenza. Conditions were reviewed and aggregated into clinical categories. We compared trends in diagnoses between influenza cases and controls using a difference-in-differences approach. Results: We identified 67 diagnostic categories with significantly increased incidence post-influenza infection. Both commonly known sequelae, such as pneumonia and otitis media as well as less expected findings, such as acute kidney failure and oral candidiasis were identified. The duration of elevated risk varied by condition, ranging from a week (eg, rhabdomyolysis) to 5 weeks (eg, hemoptysis) or 8 weeks (eg, chronic bronchitis). Conclusions: We found that influenza is associated with conditions not typically considered. Also, some symptoms last longer than commonly appreciated, suggesting that some patients may suffer from a prolonged illness due to the influenza infection. Our findings have important implications for not only demonstrating the full burden of influenza but also informing future studies to prevent or treat influenza.

Indexed as

influenzasequelaesymptoms

Identifiers

PMID42871849
PMCPMC13660689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.